Showing results (431-440 of 1,609) with videos related to
Sort By:
Pageof 161
JAMA Oncology|March 25, 2016
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor ClinicSosipatros A Boikos, Alberto S Pappo, J Keith Killian, et al.JAMA Oncology|May 20, 2016
Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among White Adults in the United StatesMingyang Song, Edward GiovannucciJAMA Oncology|April 8, 2016
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung CancerAdrian G Sacher, Cloud Paweletz, Suzanne E Dahlberg, et al.JAMA Oncology|May 27, 2016
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United StatesPaige Maas, Myrto Barrdahl, Amit D Joshi, et al.JAMA Oncology|June 3, 2016
Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor StudyMukta Arora, Can-Lan Sun, Kirsten K Ness, et al.JAMA Oncology|June 3, 2016
Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal CancerThomas Powles, Naveed Sarwar, Andrew Stockdale, et al.JAMA Oncology|June 10, 2016
Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without LapatinibAleix Prat, Maggie C U Cheang, Patricia Galván, et al.JAMA Oncology|July 15, 2016
Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell TransplantationLise J Estcourt, Simon J Stanworth, Michael F MurphyJAMA Oncology|July 28, 2017
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialShuzhen Liu, Bingshu Chen, Samantha Burugu, et al.JAMA Oncology|June 17, 2016
Biomarkers for the Clinical Use of PD-1/PD-L1 Inhibitors in Non-Small-Cell Lung Cancer: A ReviewAdrian G Sacher, Leena GandhiPageof 161